Nitric Oxide Holds Promise for Better Antibiotics

Researchers may improve antibiotics by targeting nitric oxide in bacteria

November 13, 2009

Tough pathogens, such as anthrax and MRSA, depend on nitric oxide to defend themselves against antibiotic drugs, according to recent research. Targeting this line of defense may lead to new tactics for fighting even the nastiest bacterial infections.

Although doctors have prescribed antibiotics to treat infections for well over 50 years, many bacteria have developed resistance to these treatments, prompting drug companies to spend millions of dollars developing alternative forms of the drugs. Even more troublesome have been specific bacteria, including strains of Staphylococcus, which defy most known antibiotics. Yet, with the new discovery of how bacteria defend themselves with nitric oxide, scientists now hope that by merely blocking the site of nitric oxide production in bacteria they can make traditional antibiotics much more potent against even incredibly virulent infections.

“If you make bacterial cells more vulnerable to the old and well-established antibiotics, that is better than having to design new antibiotics,” explains New York University biochemist Evgeny Nudler, who led a research team that recently showed bacteria are virtually defenseless when they are unable to produce nitric oxide. Nudler, along with group members Ivan Gusarov and Konstantin Shatalin, published their findings in a September issue of the journal Science.

Although the nitric oxide molecule is the true culprit — it interrupts the destructive chemical pathway launched by an antibiotic — Nudler believes the best offense against bacteria will be attacking the compound’s production site, known as nitric oxide synthase, or NOS. Drug developers have already identified and tested molecules that block similar NOS enzymes in humans. Although these particular drugs were designed to target the human nitric oxide pathways that are involved in blood pressure disorders, the same technology may be tuned to specifically target bacteria.

Treating bacterial infections with cocktails of traditional antibiotics and NOS inhibitors to prevent nitric oxide formation will be more efficient than designing entirely new drugs, suggests Nudler. An important advantage of this approach is that each of the individual drugs that make up the new therapy have already undergone independent tests for human safety; a combined therapy should therefore not require the arduous drug screening that entirely new antibiotics have to endure.

To test this proposed therapy, Nudler’s team has already moved on to testing drug combinations in mice, with the help of collaborators from the University of California, San Diego.

The recent studies, which both demonstrated nitric oxide’s role in helping bacteria stave off the effects of antibiotics and paved the way for its potential therapeutic applications, have excited Nudler’s colleagues.

“This work very nicely demonstrates that bacteria that produce nitric oxide use it to protect themselves against the lethal effects of antibiotics, and that this is a broad effect,” says Jim Collins, a biomedical engineer at Boston University. Collins studies how antibiotics act to promote bacteria death.

While antibiotics have long been used to fight bacteria, exactly how the drugs caused cell death remained a mystery until 2007, when Collins’ group demonstrated that many antibiotics rely on destructive oxidizing agents in order to ravage the bacteria from the inside out.

But if this was the poison, the question remained: what did the bacteria use as an antidote to help themselves stay alive? The identification of nitric oxide’s role in bacterial defense has provided a valuable answer, one that might make researchers reevaluate antibiotic design.

With his studies of a dual-drug system already underway in mice, Nudler believes they can quickly evaluate this new strategy. “The endpoint is very clear,” he says. “You clean out an infection or not. If it works, you can easily see it.”

About the Author

Alyson Kenward

Alyson Kenward studied chemistry at the University of Calgary. After five years of trying to keep yellow mixtures from turning orange, she decided it was time to swap her lab coat for a laptop and get down to the business of being a writer of all things science-related. Although she misses how her stir plates used to serenade her, she was happy to recall just how much she loves writing. In her spare time, she enjoys exploring the central New Jersey wilderness.



James says:

Great article. I really enjoyed your writing style.

Garrett says:

Really great information, I really enjoyed reading it.

Ageless Male says:

My developer is trying to convince me to move to .

net from PHP. I have always disliked the idea because of the costs.
But he’s tryiong none the less. I’ve been using WordPress on
several websites for about a year and am worried about
switching to another platform. I have heard excellent things about blogengine.
net. Is there a way I can transfer all my wordpress content into it?
Any kind of help would be greatly appreciated!

vievie says:

Good info.. and really give me more information about antibiotics.. thanks :-)

Chuck says:

you are speaking out of your a*** seeplumpnts can cause acne, psycho-social issues, complications, etc you are talking out of your a*** . age has nothing to do with acne either. You are more prone to have acute acne at an older age than when your 15. You are right with creatine and isolate whey not being the cause of acne, but it does have other negative and nasty effects some will not appreciate. There are numerous types of steroids. moron. Go take a nutrition course.

Leave a Reply

Your email address will not be published. Required fields are marked *


The Scienceline Newsletter

Sign up for regular updates.